Mark Eller

Mark Eller is the SVP of R&D at Aria Pharmaceuticals. Mark Eller brings 30 years of pharmaceutical R&D experience, including VP/SVP roles leading teams from discovery through approval.

Mark’s previous experience encompasses both large (Quintiles, HMR/Sanofi predecessors) and small-to-midsize pharma companies (Jazz Pharmaceuticals) spanning a broad range of therapeutic areas. Mark has four FDA-approved drugs to his credit and is a co-inventor on 30 patents.

In addition, he has led health authority presentations and negotiations, including six FDA advisory committee meetings. He has co-authored numerous scientific publications and served as an Adjunct Professor of Pharmaceutics at the University of Cincinnati.

Mark received his Pharmacy degree and Ph.D. in Pharmaceutics from the University of Iowa.